Daiichi Sankyo Hong Kong Ltd. clinical trials
A country office of Daiichi Sankyo
The registry lists 1 studies whose lead sponsor is Daiichi Sankyo Hong Kong Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 18, 2022.
Registry sponsor names on this page
- Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company1 study
Something wrong with this grouping? Tell us on the Daiichi Sankyo page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Daiichi Sankyo studies →
- Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)CompletedNCT03247582
Sponsor listed in the registry: Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company